相关实验视频
Updated: May 23, 2025

10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
25.7K
避孕药和糖尿病 Mellitus 的使用.
Theodoros Panou1, Evanthia Gouveri1, Angeliki Gerede2
1Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece.
概括
患有糖尿病的女性经常使用无效的避孕措施,并面临药物相互作用. 像植入物和宫内节育器这样的安全选择可用,但新的糖尿病药物可能会影响口服避孕药的有效性.
科学领域:
- 内分泌学 在内分泌学.
- 生殖健康 生殖健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 患有糖尿病 (DM) 的女性在避孕方面有独特的考虑.
- 在这个人群中,医生和患者之间有限的讨论和不理想的避孕方法选择是普遍存在的.
- 抗糖尿病药物和荷尔蒙避孕药之间的潜在药物相互作用引起了重大关注.
研究的目的:
- 审查目前有关糖尿病女性避孕的数据.
- 突出DM女性避孕咨询和方法选择方面的挑战.
- 在糖尿病的背景下评估各种避孕方法的安全性和有效性.
主要方法:
- 这项研究是对糖尿病女性避孕现有文献的叙事综述.
- 数据合成的重点是避孕方法的有效性,安全性和药物相互作用.
- 分析包括有关激素避孕药,植入物,子宫内器械和仅用孕激素的方法的信息.
主要成果:
- 大约12.5%的DM女性使用无效的避孕措施.
- 大多数抗糖尿病药物不会干扰荷尔蒙避孕药,但新药可能会降低口服避孕药的疗效.
- 植入物,子宫内装置和仅含孕激素的避孕药通常被认为是DM妇女的安全.
结论:
- 对糖尿病妇女的避孕咨询和避孕方法选择需要仔细考虑.
- 长效可逆避孕药和仅用孕激素的方法是首选的安全选择.
- 需要进一步的研究来澄清口服避孕药对糖尿病并发症的长期影响以及新型抗糖尿病药对激素避孕药的影响.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Pathophysiology of Diabetes
839
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
839
Diabetes: Management and Pharmacotherapy
222
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
222
Oral Hypoglycemic Agents: Biguanides and Glitazones
149
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
149
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
141
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
141

